| Accession Number | 0000943819-26-000043 |
|---|---|
| Form Type | 4 |
| Filing Date | Aug 11, 2026 |
| Document | View SEC Filing |
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | ResMed Common Stock | โ | Aug 7, 2026 | Exercise/Conversion | 4,991 | $146.34 | $730,382.94 | 471,247 | Direct | โ | View Details | |
Director | ResMed Common Stock | โ | Aug 7, 2026 | Sale | 4,991 | $205.69 | $1,026,596.29 | 466,256 | Direct | โ | View Details | |
Director | ResMed Common Stock Options | Derivative | Aug 7, 2026 | Exercise/Conversion | 4,991 | $0.00 | $0.00 | 14,975 | Direct | โ | View Details |